SCHEMBL12307453

SCHEMBL12307453

CNC(=O)Nc1cc2n(n1)CCN2C(=O)c1ccccc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ USP2 O75604 1/20 0.44
▸ HTT P42858 1/20 0.43
▸ TSHR P16473 2/20 0.41
▸ ACHE P22303 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ RAB9A P51151 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12307459 0.86 GRM5 (0.37) ALDH1A1HTTTSHRALOX15KDM4E
SCHEMBL12307442 0.85 GRM5 (0.39) ALDH1A1HTTNPC1RXFP1KDM4E
SCHEMBL12307479 0.83 PLK1 (0.41) ALDH1A1USP2HTTNPC1KDM4E
SCHEMBL12307391 0.82 GRM5 (0.45) ALDH1A1ALOX15CYP2C19RAB9AMEN1
SCHEMBL12307493 0.81 HTT (0.49) ALDH1A1HTTTSHRNPC1ALOX15
SCHEMBL12307529 0.81 GAA (0.39) ALDH1A1USP2CYP2C9CYP2C19RAB9A
SCHEMBL12307393 0.81 L3MBTL1 (0.43) ALDH1A1HTTTSHRNPC1RAB9A
SCHEMBL12307455 0.80 MAPT (0.46) ALDH1A1TSHRNPC1HSD17B10RAB9A
SCHEMBL12307396 0.77 GCK (0.44) GAA
SCHEMBL12307481 0.77 TP53 (0.46) NPC1KDM4ECYP2C9CYP2C19RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed
EP-2327704-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY Shionogi&Co., Ltd. (JP) 2011-06-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY PIK3R5, PIK3R4, PIK3R1 ALDH1A1 3559/4885USP2 2401/4885HTT 3749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback